NPY Signaling Inhibits Extended Amygdala CRF Neurons to Suppress Binge Alcohol Drinking
Pleil, Kristen E.
Rinker, Jennifer A.
Lowery-Gionta, Emily G.
Mazzone, Christopher M.
McCall, Nora M.
Kendra, Alexis M.
Grant, Kathleen A.
Thiele, Todd E.
Kash, Thomas L.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationPleil, K. E., J. A. Rinker, E. G. Lowery-Gionta, C. M. Mazzone, N. M. McCall, A. M. Kendra, D. P. Olson, et al. 2015. “NPY Signaling Inhibits Extended Amygdala CRF Neurons to Suppress Binge Alcohol Drinking.” Nature neuroscience 18 (4): 545-552. doi:10.1038/nn.3972. http://dx.doi.org/10.1038/nn.3972.
AbstractSummary paragraph Binge alcohol drinking is a tremendous public health problem because it leads to the development of numerous pathologies including alcohol abuse, and anxiety1–4. It is thought to do so by hijacking brain systems that regulate stress and reward, including neuropeptide Y (NPY) and corticotropin–releasing factor (CRF). The central actions of NPY and CRF play opposing functional roles in the regulation of emotional and reward–seeking behaviors; therefore, dysfunctional interactions between these peptidergic systems could play a role in the development of these pathologies. Here, we used converging physiological, pharmacological, and chemogenetic approaches to identify a precise neural mechanism in the bed nucleus of the stria terminalis (BNST), a limbic brain region involved in pathological reward and anxiety behaviors, underlying the interactions between NPY and CRF in the regulation of binge alcohol drinking in both mice and monkeys. We found that NPY Y1 receptor (Y1R) activation in the BNST suppressed binge alcohol drinking by enhancing inhibitory synaptic transmission specifically in CRF neurons via a novel, Gi-mediated, PKA-dependent postsynaptic mechanism. Further, chronic alcohol drinking led to persistent alterations in Y1R function in the BNST of both mice and monkeys, highlighting the enduring, conserved nature of this effect across mammalian species. Together, these data provide both a cellular locus and signaling framework for the development of novel therapeutics for treatment of neuropsychiatric diseases, including alcohol use disorders.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:23473925
- HMS Scholarly Articles